Transplant milestone

The Blood and Bone Marrow Transplant team recently celebrated a big milestone – 3,000 patients treated since the program offered the first transplants in South Carolina in 1987.

Read about the milestone
a smiling young woman sits on a hospital bed with an IV drip in the background

News

Facebook icon Twitter icon Instagram icon LinkedIn logo icon

 

Triple-negative breast cancer survivor is the go-to person for her family, community

triple negative breast cancer survivor Sarah Harry poses in a colorful dress in a swirling pattern in the garden

Sarah Harry may be retired but she is one busy woman: caregiving, church activities - and chemotherapy for herself. Despite ongoing treatment for metastatic triple-negative breast cancer, she has no interest in slowing down.

“You know, what are you going to do? Like Dr. Brescia says, ‘We’re all going to die, but you’re not dying today, kiddo,’” she said.

Read her story

an older man and two young woman pose in front of a wall that says in orange script I love you so much

For Her Dad

Shannon Phelps is riding in LOWVELO24 to finish her dad's aborted ride in LOWVELO23.

group shot of three cancer scientists in a lab at Hollings Cancer Center

Triple Negative Breast Cancer

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.
Adam Fox, M.D., pulmonologist and researcher, poses in a hallway at Hollings Cancer Center

Reflex Biomarker Testing

Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

portrait of immunologist Silvia Guglietta in her lab at Hollings Cancer Center

Unlocking Immunotherapy

A Hollings immunologist will use an American Cancer Society Research Scholar Grant to study ways to make colorectal cancer more susceptible to immunotherapy.

image of the Hollings Cancer Center building with its preserved 1913 facade of columns and brick

P. gingivalis and Cancer

An MUSC Hollings Cancer Center team describes how the bacteria Porphyromonas gingivalis connects to chemotherapy resistance.

Dr. Christina Voelkel-Johnson

Monster Cancer Cells

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.
two women and a man, all researchers in the Barnoud Lab at Hollings Cancer Center, pose in the lab

Targeting Pancreatic Cancer

A new study from Hollings researchers suggests a dual approach for targeting pancreatic cancer.

shot of the backs of people's t-shirts as they walk down a dock The white shirts with blue graphics say Hollings He-Rows with a stylized image of a dragon

Dragon Boat Charleston

Members of the Hollings and MUSC community enthusiastically support Dragon Boat Charleston every year.

a nurse leans over a monitor while in the background a patient sits in a chair with a cuff around his arm

Cancer Clinical Trials

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

Read more news

“ What’s great is now everyone can get it. Anyone can prescribe it. They don’t have to travel somewhere to get this medication. It really is a huge help for our families and kids. ”

Dr. Jacqueline Kraveka, pediatric cancer researcher

Read about the new drug
Jacqueline Kraveka headshot

 

Featured video

An ovarian cancer diagnosis was the last thing that Carol Sullivan expected. But with support from friends and family and her care team at MUSC Hollings Cancer Center, she's successfully come through treatment. Watch her inspiring story below.

Explore the News Center

Hollings Horizons Magazine   |   Media Relations   |   Cross Talk   |   Subscribe

Visit the News Archive
Contact Us
Check out our Multimedia